BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 37378783)

  • 1. Statins: Beneficial Effects in Treatment of COVID-19.
    Lashgari NA; Roudsari NM; Shamsnia H; Shayan M; Momtaz S; Abdolghaffari AH; Matbou Riahi M; Jamialahmadi T; Guest PC; Reiner Ž; Sahebkar A
    Adv Exp Med Biol; 2023; 1412():457-476. PubMed ID: 37378783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins and SARS-CoV-2 disease: Current concepts and possible benefits.
    Minz MM; Bansal M; Kasliwal RR
    Diabetes Metab Syndr; 2020; 14(6):2063-2067. PubMed ID: 33120281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting pivotal inflammatory pathways in COVID-19: A mechanistic review.
    Yarmohammadi A; Yarmohammadi M; Fakhri S; Khan H
    Eur J Pharmacol; 2021 Jan; 890():173620. PubMed ID: 33038418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19: Direct and Indirect Mechanisms of Statins.
    Pawlos A; Niedzielski M; Gorzelak-Pabiś P; Broncel M; Woźniak E
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Potential Impact of Statins in the Treatment of Patients with COVID-19 Infection.
    Esfehani RJ; Vojdanparast M; Soleimanpour S; Ferns GA; Avan A
    Adv Exp Med Biol; 2021; 1352():149-158. PubMed ID: 35132599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lidocaine reinforces the anti-inflammatory action of dexamethasone on myeloid and epithelial cells activated by inflammatory cytokines or SARS-CoV-2 infection.
    Elizagaray ML; Mazitelli I; Pontoriero A; Baumeister E; Docena G; Raimondi C; Correger E; Rumbo M
    Biomed J; 2023 Feb; 46(1):81-92. PubMed ID: 35948250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological mechanism of immunomodulatory agents for the treatment of severe cases of COVID-19 infection.
    Bahari Z; Jangravi Z; Ghoshooni H; Afarinesh MR; Meftahi GH
    Inflamm Res; 2021 Apr; 70(4):389-405. PubMed ID: 33608746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IDO/Kynurenine; novel insight for treatment of inflammatory diseases.
    Lashgari NA; Roudsari NM; Shayan M; Niazi Shahraki F; Hosseini Y; Momtaz S; Abdolghaffari AH
    Cytokine; 2023 Jun; 166():156206. PubMed ID: 37120946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plausible Positive Effects of Statins in COVID-19 Patient.
    Vitiello A; Ferrara F
    Cardiovasc Toxicol; 2021 Oct; 21(10):781-789. PubMed ID: 34255300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammatory Action of Statins in Cardiovascular Disease: the Role of Inflammasome and Toll-Like Receptor Pathways.
    Koushki K; Shahbaz SK; Mashayekhi K; Sadeghi M; Zayeri ZD; Taba MY; Banach M; Al-Rasadi K; Johnston TP; Sahebkar A
    Clin Rev Allergy Immunol; 2021 Apr; 60(2):175-199. PubMed ID: 32378144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of toll-like receptors in modulation of cytokine storm signaling in SARS-CoV-2-induced COVID-19.
    Manik M; Singh RK
    J Med Virol; 2022 Mar; 94(3):869-877. PubMed ID: 34672376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview of possible pivotal mechanisms of Genistein as a potential phytochemical against SARS-CoV-2 infection: A hypothesis.
    Jafari A; Esmaeilzadeh Z; Khezri MR; Ghasemnejad-Berenji H; Pashapour S; Sadeghpour S; Ghasemnejad-Berenji M
    J Food Biochem; 2022 Oct; 46(10):e14345. PubMed ID: 35866873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins in COVID-19: is there any foundation?
    Lima Martínez MM; Contreras MA; Marín W; D'Marco L
    Clin Investig Arterioscler; 2020; 32(6):278-281. PubMed ID: 32718669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNF-α/IFN-γ synergy amplifies senescence-associated inflammation and SARS-CoV-2 receptor expression via hyper-activated JAK/STAT1.
    Kandhaya-Pillai R; Yang X; Tchkonia T; Martin GM; Kirkland JL; Oshima J
    Aging Cell; 2022 Jun; 21(6):e13646. PubMed ID: 35645319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential role of statins in COVID-19.
    Lee KCH; Sewa DW; Phua GC
    Int J Infect Dis; 2020 Jul; 96():615-617. PubMed ID: 32502659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The advantages of drug treatment with statins in patients with SARS-CoV-2 infection.
    Ferrara F; Vitiello A
    Wien Klin Wochenschr; 2021 Sep; 133(17-18):958-965. PubMed ID: 33779831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins and Covid-19: The Neglected Front of bidirectional effects.
    Hussien NR; Al-Niemi MS; Al-Kuraishy HM; Al-Gareeb AI
    J Pak Med Assoc; 2021 Dec; 71(Suppl 8)(12):S133-S136. PubMed ID: 35130236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiplex Testing of the Effect of Statins on Disease Severity Risk in COVID-19 Cases.
    Zahedipour F; Guest PC; Majeed M; Al-Rasadi K; Jamialahmadi T; Sahebkar A
    Methods Mol Biol; 2022; 2511():273-284. PubMed ID: 35838967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs based regulation of cytokine regulating immune expressed genes and their transcription factors in COVID-19.
    Khokhar M; Tomo S; Purohit P
    Meta Gene; 2022 Feb; 31():100990. PubMed ID: 34722158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronavirus Disease-2019 Treatment Strategies Targeting Interleukin-6 Signaling and Herbal Medicine.
    Dzobo K; Chiririwa H; Dandara C; Dzobo W
    OMICS; 2021 Jan; 25(1):13-22. PubMed ID: 32857671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.